Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2013 Mar 5;288(16):11294–11303. doi: 10.1074/jbc.M113.458133

Structural Sensitivity of a Prokaryotic Pentameric Ligand-gated Ion Channel to Its Membrane Environment*

Jonathan M Labriola , Akash Pandhare §, Michaela Jansen , Michael P Blanton §, Pierre-Jean Corringer , John E Baenziger ‡,1
PMCID: PMC3630840  PMID: 23463505

Background: The lipid sensitivity of the prokaryotic pentameric ligand-gated ion channel (pLGIC), GLIC, is poorly characterized.

Results: GLIC is more thermally stable and does not exhibit the same propensity to adopt an uncoupled conformation as the Torpedo nAChR.

Conclusion: GLIC is less sensitive to its surrounding membrane environment.

Significance: The GLIC and nAChR structures suggest molecular features governing the lipid sensitivity of pLGICs.

Keywords: Membrane, Membrane Reconstitution, Nicotinic Acetylcholine Receptors, Protein Structure, Reconstitution of Membrane Transporters, Function, Membrane Sensitivity, Prokaryotic Pentameric Ligand-gated Ion Channels, Structure, Uncoupling of Binding and Gating

Abstract

Although the activity of the nicotinic acetylcholine receptor (nAChR) is exquisitely sensitive to its membrane environment, the underlying mechanisms remain poorly defined. The homologous prokaryotic pentameric ligand-gated ion channel, Gloebacter ligand-gated ion channel (GLIC), represents an excellent model for probing the molecular basis of nAChR sensitivity because of its high structural homology, relative ease of expression, and amenability to crystallographic analysis. We show here that membrane-reconstituted GLIC exhibits structural and biophysical properties similar to those of the membrane-reconstituted nAChR, although GLIC is substantially more thermally stable. GLIC, however, does not possess the same exquisite lipid sensitivity. In particular, GLIC does not exhibit the same propensity to adopt an uncoupled conformation where agonist binding is uncoupled from channel gating. Structural comparisons provide insight into the chemical features that may predispose the nAChR to the formation of an uncoupled state.

Introduction

Cys-loop receptors mediate rapid chemical communication between cells in the nervous system by opening a transmembrane ion channel across the synaptic membrane in response to neurotransmitter binding. Channel opening leads to the flow of either cations or anions down their electrochemical gradient into the cell, resulting in either an excitatory or an inhibitory response, respectively. Cys-loop receptors play a central role in brain function, are implicated in a variety of neurological disorders, and are the targets of both endogenous and exogenous modulators (15).

Early attempts at purifying and reconstituting the prototypic Cys-loop receptor, the Torpedo nicotinic acetylcholine receptor (nAChR),2 in lipid bilayers revealed the importance of lipids in Cys-loop receptor function (6). In the presence of both cholesterol and anionic lipids, the nAChR is stabilized predominantly in an activatable resting conformation (710). In their absence, the nAChR adopts an “uncoupled” conformation, where agonist binding fails to elicit channel gating (11). Understanding the mechanisms by which lipids influence the coupling of binding and gating remains central to understanding lipid-nAChR interactions. Uncoupled nAChRs may also have broader significance in that neuronal nAChRs that are functionally uncoupled have been observed in heterologous expression systems and may play a role in the physiological response to nicotine (12). Unfortunately, detailed insight into the mechanisms of lipid-dependent uncoupling remains elusive (11, 13). A major bottleneck is the inability to reliably express large quantities of Cys-loop receptors with site-directed mutations designed to test potential models of lipid-nAChR interactions.

Several prokaryotic pentameric ligand-gated ion channels (pLGICs) homologous to the eukaryotic Cys-loop receptors have recently been identified, and crystal structures of two of these solved at high resolution (1417). Prokaryotic pLGICs provide an opportunity for probing the mechanisms of Cys-loop receptor-lipid interactions at a molecular level because of their high structural homology (Fig. 1), their relative ease of expression in bacterial systems, and their amenability to crystallographic analysis. Although a recent study suggested that cholesterol depletion may influence the gating kinetics of one pLGIC, GLIC (18), the broader effects of lipids on prokaryotic pLGIC structure and function remain to be studied. In fact, a reliable protocol for reconstituting prokaryotic pLGICs in membranes at lipid to protein ratios that are amenable to spectroscopic studies, particularly in the context of probing the electrophysiologically silent uncoupled state, has yet to be developed.

FIGURE 1.

FIGURE 1.

The structures of GLIC (A, Protein Data Bank code 3EAM) and the Torpedo nAChR (B, Protein Data Bank code 2BG9). Both structures are side views from within the plane of the membrane. Coloring highlights the domain structure: the extracellular agonist-binding domain (ABD) in red, the transmembrane domain (TMD) in blue, and the cytoplasmic domain (CD) in green.

Here, we compare the structural and biophysical properties of membrane-reconstituted GLIC with those of its highly lipid-sensitive eukaryotic homolog, the Torpedo nAChR. These comparisons were performed both in membranes that support GLIC/nAChR function and in those that promote formation of the uncoupled nAChR. Our results suggest that although the gating properties of GLIC are sensitive to its lipid environment, GLIC does not possess the exquisite lipid sensitivity of its eukaryotic homolog. In particular, GLIC does not exhibit the same propensity to adopt an uncoupled conformation where agonist binding is uncoupled from channel gating. Structural comparisons provide insight into the chemical features that may predispose Cys-loop receptors to the formation of an uncoupled state.

EXPERIMENTAL PROCEDURES

Materials

Soybean asolectin (l-α-phosphatidylcholine, type II-S), sodium cholate, carbamylcholine (Carb), and amantadine were from Sigma. Escherichia coli polar lipid extracts and 1-palmotyl-2-oleoyl-sn-glycero-3-phosphocholine were from Avanti (Alabaster, AL). Torpedo californica electroplaque organ was from Aquatic Research Consultants (San Pedro, CA). Dodecylmaltoside (DDM) was from Affymetrix (Santa Clara, CA). [125I]α-Bungarotoxin (107 Ci/mmol) was obtained from PerkinElmer Life Sciences. Nonradioactive α-bungarotoxin was from Biotium, Inc. (Hayward, CA).

GLIC Expression and Purification

GLIC was expressed in the C43 strain of E. coli transformed with a pET-20b(+) vector containing the DNA sequence for the maltose-binding protein fused to the N terminus of GLIC through a thrombin-sensitive peptide linker (14). Briefly, 2-liter cultures of the transformed C43 cells were grown in 2YT medium containing 50 μg/ml ampicillin at 37 °C to an A600 of ∼1.2, and the cultures were induced overnight at 30 °C with 100 μm isopropyl β-d-thiogalactopyranoside. The cells were harvested, resuspended in Buffer A (250 mm NaCl, 25 mm Tris, pH 7.2) in the presence of Roche CompleteTM antiprotease tablets, and lysed with an Avestin Emulsiflex-C5 homogenizer (Ottawa, Canada). Membrane fractions were solubilized in 1% DDM in Buffer A, and the GLIC fusion protein was bound to an amylose affinity resin. After treatment with plasminogen-free thrombin from Calbiochem (Gibbstown, NJ), GLIC was eluted in 0.02% DDM and further purified on a Superpose 6 10/300 gel filtration column (GE Healthcare). The highly purified GLIC was passed quickly through 1 ml of amylose resin to remove small amounts of an endogenous amylose binding protein that co-elutes with GLIC from the size exclusion column.

Membrane Reconstitution of GLIC

The purified GLIC in 0.02% DDM in buffer A was slowly diluted at least 1:4 with lipids solubilized in 0.625% cholate in Buffer A to give the desired final lipid to protein ratio, in this case 2:1 (w/w) (19, 20). After gently mixing for ∼30 min, the protein/detergent/lipid mixture was dialyzed five times at 4 °C against 2 liters of Buffer A leading to a turbid solution of proteoliposomes, which were harvested by ultracentrifugation at 100,000 × g for 2 h. The pelleted membranes were resuspended and layered onto a discontinuous sucrose density gradient. After ultracentrifugation at 100,000 × g for 20 h in a Beckman SW41 swinging bucket rotor, sequential 400-μl aliquots were removed and assayed for both protein (BCATM assay from Thermo-Pierce) and lipid (phospholipid C/choline assay from Wako Chemicals (Richmond, VA)). Appropriate fractions were pooled and either dialyzed a further five times or subjected to several centrifugation resuspension cycles to remove sucrose.

Reconstituted nAChR Membranes

nAChR purification and reconstitution was performed as described (11, 21). The nAChR was solubilized from Torpedo electroplaques with 1% sodium cholate and purified on a bromoacetylcholine affinity column in the presence of lipid. Protein was eluted with 10 mm Carb, and then the membrane was reconstituted by dialysis.

Fourier Transform Infrared Spectroscopy

Hydrogen/deuterium infrared spectra (Fig. 2A) were recorded on a Digilab (now Agilent Technologies (Santa Clara, CA)) FTS40 spectrometer using a Golden-GateTM attenuated total internal reflection accessory (SpecAc; Oprington (Kent, UK)). 10 μl of the membrane-reconstituted GLIC (∼1 mg/ml) in 2 mm phosphate buffer (pH 7.0) were dried down onto the accessory under a gentle stream of N2 gas. After collecting a 64-scan spectrum at 4 cm−1 resolution, 10 μl of buffer A in 2H2O was added, and another 64-scan spectrum was collected.

FIGURE 2.

FIGURE 2.

Structural comparisons of membrane-reconstituted GLIC and the nAChR as probed by infrared spectroscopy. A, infrared spectra of aso-GLIC recorded after gentle drying from 1H2O buffer (solid black line) and immediately after addition of 2H2O (dashed gray line). Note the immediate changes in amide I band shape (1700–1600 cm−1) and the immediate decrease in amide II band intensity (1547 cm−1), both indicative of the rapid peptide N-1H/N-2H exchange of solvent-exposed peptide hydrogens. Similar spectral effects are observed for other Cys-loop receptors (supplemental Fig. S2). B, infrared spectra recorded after 72 h of equilibration in 2H2O at 4 °C from aso-GLIC (spectrum i), EcoLip-GLIC (spectrum ii), PC-GLIC (spectrum iii), aso-nAChR (spectrum iv), and PC-nAChR (spectrum v). The left column shows the secondary structure-sensitive amide I band both before (gray traces) and after resolution enhancement (black traces) (intensity scaling arbitrary). The right column shows the amide II band in each spectrum. The relative intensity of the amide II vibration is best assessed relative to the intensity of the adjacent broad peak between 1560 and 1600 cm−1, because of aspartic and glutamic acid residues. All of the presented spectra are the averages of several spectra recorded from at least two different purification/reconstitutions.

For the more detailed amide I band analyses (Fig. 2B) and for thermal stability measurements, the membrane-reconstituted GLIC was exchanged into 2 mm phosphate 2H2O buffer, pH 7.0, for precisely 72 h at 4 °C and then stored at −80 °C until use. Approximately 125 μg of GLIC was deposited on a CaF2 window with a gentle stream of N2 gas followed by rehydration with 8 μl of Buffer A in 2H2O, pH 7.0. A 4000-scan spectrum was collected at 2 cm−1 resolution and 22.5 °C on a Digilab (now Agilent Technologies) FTS7000 spectrometer. 128-scan spectra were then acquired at 1 °C intervals from 35 to 90 °C with a 20-min equilibration period between each temperature jump.

The spectra were analyzed using GRAMS/AI software (Thermo Scientific, Waltham, MA). Residual water vapor was subtracted using the method of Reid et al. (22). Resolution enhancement was performed between 1900 and 1300 cm−1 using a γ = 7 and a Bessel smoothing function set to 70%. Thermal denaturation was measured as the change in intensity at 1681 cm−1 and was evaluated using GraphPad Prism (La Jolla, CA) (11).

Electrophysiology

Electrophysiology was performed using a two-electrode voltage clamp apparatus (OC-725C oocyte clamp from Warner Instruments (Hamden, CT) or as described elsewhere (23). Except where noted, the oocytes were injected with 100 ng of membrane-reconstituted GLIC or nAChR or 6.6 ng of GLIC mRNA and allowed to incubate for 1–2 days at 16 °C in ND96+ buffer (5 mm HEPES, 96 mm NaCl, 2 mm KCl, 1 mm MgCl2, 1 mm CaCl2, and 2 mm pyruvate). Injected oocytes were placed in a RC-1Z oocyte chamber (Harvard Apparatus, Hamden, CT) containing MES buffer (140 mm NaCl, 2.8 mm KCl, 2 mm MgCl2, and 10 mm MES, pH 7.0). Currents through the plasma membrane in response to pH jumps were measured with the transmembrane voltage-clamped at between −20 and −60 mV. The oocyte chamber was perfused with MES buffer at a rate of ∼5 ml/min.

α-Bungarotoxin Binding Assays

Individual oocytes were incubated with 2.58 nm [125I]α-bungarotoxin for 2 h at room temperature. The oocytes were washed three times with 1 ml of ice-cold buffer containing 1% BSA, and then binding was quantified by γ-counting. Nonspecific binding was determined with oocytes from the same batch incubated with 5 μm nonlabeled α-bungarotoxin.

RESULTS

Membrane Reconstitution of GLIC

GLIC was reconstituted into membranes at a lipid to protein ratio of 2:1 (w/w), because this ratio is ideal for spectroscopic studies, such as those used previously to characterize the uncoupled nAChR (see “Discussion”) (11). To reconstitute into model membranes, DDM-solubilized GLIC (supplemental Fig. S1) was diluted below the critical micellar concentration for DDM with a cholate-solubilized lipid solution, and the protein/detergent/lipid mixture was dialyzed extensively to remove residual DDM and cholate. Sucrose density gradients showed that GLIC efficiently incorporates into model membranes. Neither residual DDM nor cholate could be detected in the reconstituted membranes using an infrared based assay for detergent (24). GLIC was initially reconstituted into membranes composed of either asolectin lipids (aso-GLIC) or E. coli polar lipid extracts (EcoLip-GLIC). These membranes were chosen because asolectin lipids (as well as defined membranes composed of phosphatidylcholine, phosphatidic acid, and cholesterol (PC/PA/Chol) 3:1:1 (molar ratios)) stabilize the nAChR in a functional resting conformation and minimize GLIC aggregation (18), whereas E. coli polar lipid extracts likely resemble the natural lipid environment of GLIC. We expected both membranes to stabilize an activatable “resting” conformation.

Structure of Membrane-reconstituted GLIC

Infrared spectra of both aso-GLIC and EcoLip-GLIC gently dried from 1H2O buffer (to eliminate the intense overlapping vibrations of bulk water) exhibit two relatively intense protein bands: the amide I band between 1700 and 1600 cm−1 and the amide II band centered near 1547 cm−1 (Fig. 2A). The amide I band is due primarily to peptide backbone C=O stretching vibrations and is sensitive to protein secondary structure. The amide II band, primarily due to peptide backbone C-N stretching vibrations coupled to N-1H bending vibrations, is also sensitive to secondary structure but is used primarily to monitor the exchange of peptide N-1H to N-2H. The amide II band shifts down in frequency from 1547 cm−1 to near 1450 cm−1 in 2H2O, the downshifted vibration often referred to as the amide II′ band.

The GLIC amide I contour observed in spectra dried from 1H2O exhibits a peak maximum near 1655 cm−1, due to the overlapping vibrations of α-helix and loop/random secondary structures, and a prominent broad shoulder between 1640 and 1625 cm−1, primarily due to the vibrations of β-sheet. The amide I band shape is similar to that observed for functional membrane-reconstituted Torpedo nAChRs (supplemental Fig. S2), suggesting a similar mixed α-helix/β-sheet secondary structure. The slightly increased intensity between 1640 and 1620 cm−1 indicates a slightly higher β-sheet content in GLIC.

The mixed α-helix/β-sheet secondary structure of the reconstituted GLIC was confirmed by recording spectra in 2H2O buffer, where there is no overlap of the solvent vibrations with the amide I band (Fig. 2B). The resulting amide I contour still exhibits features at frequencies characteristic of both α-helix (1655 cm−1) and β-sheet (1640–1625 cm−1), as shown clearly by resolution enhancement. Curve fitting (supplemental Fig. S3) suggests roughly 35% α-helix and 40% β-sheet (supplemental Fig. S3), estimates that compare well with the crystal structure (roughly 35% α-helices with >5 residues and 30% β-sheet). The slight overestimate of β-sheet content could reflect difficulties precisely defining the start and end point of each β-strand in the crystal structure. In addition, spectra of the α-helical protein myoglobin (no β-sheet) exhibit weak intensity between 1640 and 1620 cm−1, demonstrating that structures other than β-sheet can contribute weak intensity to this region (25).

Note that we recorded spectra both immediately after exposure to (Fig. 2A) and after prolonged equilibration with 2H2O buffer (72 h, 4 °C) (Fig. 2B). The spectra recorded immediately after exposure exhibit changes in band shape that result from the downshifts in frequency of solvent-exposed regions of the peptide backbone. Subtle downshifts in the frequencies of amide I component bands caused by turn (1700–1670 cm−1 region; see supplemental materials), loop/random and/or α-helical structures (1655 cm−1 down to ∼1645 cm−1), and β-sheet (primarily 1640–1620 cm−1 region) are detected (26). These rapid amide I band shifts are accompanied by a drop in amide II band intensity, further demonstrating the rapid exchange of peptide N-1H to N-2H. The spectral changes are all similar to those observed immediately upon exposure of other Cys-loop receptors to 2H2O (supplemental Fig. S2) (27) but differ from those typically observed for proteins with different tertiary folds (26). The results emphasize the existence of a substantial population of solvent-exposed secondary structures, consistent with the large solvent-exposed extramembranous agonist-binding domain in GLIC (16, 17).

One notable feature of the GLIC spectra is that the relatively intense 1655 cm−1 amide I component band, which is due to the vibrations of protiated and thus solvent-shielded α-helical and/or loop/random structures, is still observed in spectra recorded after prolonged exposure of GLIC to 2H2O. This suggests the existence of a large population of exchange-resistant and likely transmembrane α-helices, as has been characterized for the nAChR (25, 28). A large population of solvent-shielded peptide hydrogens is also suggested by the residual amide II band intensity (Fig. 2B). The proportion of exchange-resistant peptide hydrogens in both aso-GLIC and EcoLip-GLIC is slightly higher than in aso-nAChR, although aso-GLIC exchanges to a greater extent than EcoLip-GLIC (see “Discussion”). The proportion of exchange-resistant peptide hydrogens in aso-nAChR was estimated to be ∼40%, sufficient to account for the peptide hydrogens located in the transmembrane domain (11, 29). The greater proportion of exchange-resistant peptide hydrogens in GLIC is likely due to the lack of an intracellular domain: the exchange-resistant transmembrane domain of GLIC makes up a greater proportion of the total protein structure (Fig. 1).

The one notable difference between the deconvolved amide I contours of GLIC and the nAChR is the existence in the latter of a more intense band centered near 1645 cm−1 caused by downshifted and thus peptide N-1H to N-2H exchanged α-helical and loop/random structures. This band appears immediately after exposure of the nAChR to 2H2O, suggesting that the affected structures are solvent-exposed (28). Solvent-exposed α-helical and loop/random structures exist in the intracellular domain of the nAChR. The lack of a similarly intense band centered near 1645 cm−1 in the GLIC spectra is consistent with the absence of an intracellular domain in GLIC.

Finally, the thermal stabilities of both aso-GLIC and EcoLip-GLIC were examined by recording infrared spectra as a function of temperature. In both cases, increasing temperature led to changes in amide I band shape characteristic of protein denaturation (supplemental Fig. S4), confirming that the reconstituted GLIC adopts a folded structure. It is noteworthy that the previously “exchange-resistant peptide hydrogens” in the transmembrane domain of GLIC undergoes complete N-1H to N-2H exchange concomitant with unfolding. This behavior is similar to that observed for the nAChR but differs from that of other membrane proteins, such as LacY, which undergoes complete N-1H to N-2H exchange at elevated temperatures, but prior to unfolding (20). The latter property of LacY has been attributed to a temperature-induced increase in the conformational dynamics of the transmembrane domain, whereas the transmembrane domain of GLIC may be conformationally “static” in the absence of bound agonist. The transmembrane domain of GLIC is also not expected to undergo such large conformational transitions (16, 17, 30). Both aso-GLIC and EcoLip-GLIC have higher thermal stabilities of 68.8 ± 1.5 and 73.7 ± 1.4 °C, respectively, than that of the nAChR ∼55 °C (Fig. 3 and Table 1). The higher thermal stability of GLIC is consistent with its enhanced suitability for crystallization (31).

FIGURE 3.

FIGURE 3.

Representative thermal denaturation curves for GLIC (black lines) and the nAChR (gray lines) in different membranes. The denaturation curves are for aso-GLIC (▴), EcoLip-GLIC (●), PC-GLIC (□), aso-nAChR (▵), PC/PA/Chol-nAChR (♦), and PC-nAChR (■). Each curve was fit with a Boltzmann sigmoid from which Td and Boltzmann slope were calculated using GraphPad Prism software (Table 1) (see supplemental materials and Ref. 11). The Boltzmann slope decreases with increasing cooperativity of unfolding.

TABLE 1.

Thermal stability of GLIC

Reconstitution Td Boltzmann slope n
aso-GLIC 68.8 ± 1.5 2.44 ± 0.16 5
EcoLip-GLIC 73.7 ± 1.4 1.98 ± 0.22 5
PC-GLIC 70.4 ± 0.9 2.35 ± 0.20 4
aso-nAChR 55.4 ± 1.0 2.25 ± 0.01 2
PC/PA/Chol-nAChRa,b 56.4 ± 0.8 2.08 ± 0.20 6
PC-nAChRb 52.4 ± 0.1 3.08 ± 0.12 6

a The nAChR in membranes composed of PC, phosphatidic acid, and cholesterol.

b From daCosta and Baenziger (11).

Gating Properties of the Membrane-reconstituted GLIC

Although reconstituted membranes at a lipid to protein ratio of 2:1 (w/w) are ideal for spectroscopic studies, they are not useful for direct measurements of channel activity using electrophysiological approaches. Instead, we indirectly probed activity by injecting the reconstituted GLIC membranes into Xenopus laevis oocytes and then monitoring the appearance of proton-activated currents across the oocyte plasma membranes using a two-electrode voltage clamp apparatus (23, 32).

We first tested the feasibility of this approach using reconstituted nAChR membranes of defined function. Carb-induced currents that decay slowly because of desensitization are observed in oocytes injected with either aso-nAChR or PC/PA/Chol-nAChR, showing that the functional reconstituted nAChR membranes fuse with the oocyte plasma membrane, leading to the appearance of functional nAChRs on the oocyte surface (16 fmol of binding sites/oocyte, with 0.124 ± 0.061 μA/fmol [125I]α-bungarotoxin-binding sites/oocyte; Fig. 4). In contrast, weak or negligible Carb-induced currents were observed in oocytes injected with the uncoupled and nonactivatable PC-nAChR, even though the reconstituted PC membranes fuse with the plasma membrane leading to the appearance of nAChR agonist sites on the surface of the oocyte (5.5 fmol of [125I]α-bungarotoxin-binding sites/oocyte, with 0.0034 ± 0.0006 μA current/fmol binding sites/oocyte; Fig. 4). The lack of activity of the plasma membrane-incorporated PC-nAChR (∼40-fold reduction in normalized current levels compared with the injected PC/PA/Chol-nAChRs) has several possible explanations. First, the lack of activity could reflect clustering of the reconstituted membranes within the oocyte plasma membrane and thus the nAChR retaining its “reconstituted membrane” lipid environment. Such clustering of the nAChR on the oocyte surface has been suggested from previous studies, (32). PC-nAChR may also be locked in an uncoupled conformation because the oocyte plasma membrane lipids do not promote transitions from uncoupled to coupled conformations. Recent studies suggest that the uncoupled nAChR in long chain PC membranes can undergo ligand-induced transitions to coupled conformations (data not shown). Finally, it is possible that detergent solubilization leads to irreversible effects on nAChR structure and function. The latter seems unlikely, however, given that detergent solubilization has no deleterious effects on the nAChR reconstituted into other membranes. In addition, no detectable effects of detergent solubilization and PC reconstitution are observed on nAChR secondary structure. Regardless, these control experiments confirm that the injection of reconstituted nAChR membranes into oocytes can, in principle, be used to indirectly assess the gating activity of reconstituted nAChRs.

FIGURE 4.

FIGURE 4.

The Carb-induced response of membrane-reconstituted nAChR after injection into and consequent fusion with the plasma membrane of Xenopus oocytes. A, currents induced by 500 μm Carb were measured at −20 mV holding potential from oocytes injected with aso-nAChR (left trace) and PC-nAChR (right trace). B, a bar graph comparing maximal recorded currents, each normalized to the number of [125I]α-bungarotoxin (BTX)-binding sites, induced by 300 μm acetylcholine from individual oocytes microinjected with 125 ng of affinity-purified Torpedo nAChR protein reconstituted in either PC/PA/Chol (3:1:1 molar ratio; 0.124 ± 0.061 μA/[125I]α-bungarotoxin-binding sites/oocyte; n = 5) or PC lipid vesicles (0.0034 ± 0.0006 μA/[125I]α-bungarotoxin-binding sites/oocyte; n = 6).

We next characterized the response of uninjected, mock injected (membranes alone), and GLIC mRNA-injected oocytes to jumps in proton concentration. Both uninjected and mock injected oocytes exhibit weak proton-activated currents because of endogenous acid-sensitive channels (Fig. 5). These currents, however, show a roughly linear response to proton concentration at pH values down to 3.5, are insensitive to the GLIC pore blocker amantadine, and had maximal currents of 0.069 ± 0.016 μA (n = 4) and 0.063 ± 0.021 μA (n = 6), respectively, at the maximal utilized proton concentration (pH 3.5). In contrast, oocytes injected with GLIC RNA exhibit robust proton-activated cationic currents (supplemental Fig. S5) with relatively large maximal currents typically close to 4 μamps. A plot of whole cell currents versus proton concentration for the latter yielded a pH50 for activation of 4.82 ± 0.04 (Fig. 4B), consistent with that observed previously for oocyte-expressed GLIC (14). These proton-activated currents are sensitive to the pore blocker, amantadine. 150 μm amantadine blocked close to ∼50% of the pH-activated currents.

FIGURE 5.

FIGURE 5.

The proton-induced response of membrane-reconstituted GLIC after injection into and consequent fusion with the plasma membrane of Xenopus oocytes. A, electrophysiology recordings in response to pH jumps from uninjected oocytes and oocytes injected with aso-GLIC, EcoLip-GLIC, and PC-GLIC. The dose-response curves were measured at a relatively low membrane potential of −20 mV, because this seemed to generate more stable base lines. An electrical response to pH 4.0 showing the effect of 150 μm amantadine (gray bar) is shown on the right (scaling arbitrary). The latter were performed at a membrane potential of −60 mV. B, peak current achieved upon exposure of oocytes injected with the indicated reconstituted membranes at pH 3.5. The reported values are the averages ± standard deviation from five recordings performed on five difference oocytes. C, comparison of the dose-response curves obtained from oocytes injected with the membrane-reconstituted GLIC or GLIC mRNA. The dose-response curves from oocytes injected with membrane-reconstituted GLIC were normalized assuming a pH50 of 2.90 according to Velisetty et al. (51).

Oocytes injected with either aso-GLIC or EcoLip-GLIC both exhibit currents that respond to proton concentration in a dose-dependent manner. The maximal responses at pH 3.5 of 0.181 ± 0.008 μA (n = 5) and 0.157 ± 0.014 μA (n = 5), respectively, are roughly 3-fold larger than the responses observed in mock or uninjected oocytes yet are consistent in magnitude to the Carb-induced currents observed in aso-nAChR-injected oocytes. Of particular significance, these proton-induced currents were sensitive to the GLIC channel blocker, amantadine, whereas the endogenous acid-sensitive channels in oocytes are not. These data suggest that the reconstituted GLIC in both membranes retains the ability to gate open in response to proton binding. Interestingly, the proton concentration dependence of GLIC activation is right-shifted relative to the dose response observed with mRNA-injected oocytes, suggesting weaker proton sensitivity. A weaker proton sensitivity has also been observed for GLIC reconstituted into giant unilamellar asolectin liposomes at the high lipid to protein ratios required for electrophysiological studies (18). The right shifted dose response suggests that GLIC may also clusters within the oocytes plasma membrane, thus maintaining its reconstituted lipid environment. The shifted dose response suggests that the gating activity of GLIC is sensitive to its membrane environment.

Effects of an Uncoupling Lipid Environment on GLIC Structure and Function

We next compared the structural and functional properties of aso-GLIC and EcoLip-GLIC with that of GLIC reconstituted into PC membranes (PC-GLIC). The minimal PC environment is of interest because it stabilizes the nAChR in an uncoupled conformation that binds agonist but does not undergo agonist-induced conformational transitions. A key goal of this work was to ascertain whether GLIC exhibits the same propensity to uncouple as the nAChR in a PC bilayer.

The uncoupled PC-nAChR exhibits biophysical properties that distinguish it from the predominantly resting state aso-nAChR (Figs. 2 and 3). The secondary structure-sensitive amid I contours in spectra recorded from PC-nAChR are similar to that of aso-nAChR, but deconvolution reveals a downshift in amide I component band intensity from 1655 cm−1 to near 1645 cm−1. This change in amide I band shape occurs as a result of enhanced levels of peptide N-1H/N-2H exchange in the uncoupled state, as opposed to a change in the global secondary structure (33). The enhanced peptide N-1H/N-2H exchange is shown by the reduced residual amide II band intensity in spectra recorded from PC-nAChR versus aso-nAChR.

A more detailed analysis of the peptide N-1H/N-2H exchange kinetics of uncoupled versus resting or desensitized nAChRs shows that regions of the polypeptide backbone that are buried from solvent in the resting conformation become exposed to solvent in the uncoupled state (11). The uncoupled PC-nAChR also undergoes thermal denaturation at temperatures slightly lower than aso-nAChR, and the cooperativity of denaturation is reduced (11). These altered biophysical properties of PC-nAChR have been attributed to weakened interactions leading to an increased physical separation between the agonist-binding and transmembrane domains (11). Weakened interactions could account for the increased solvent exposure, the reduced cooperativity of unfolding, and the lack of coupling of binding and gating (supplemental Fig. S6).

Significantly, we detect little if any structural or biophysical difference between PC-GLIC and either aso-GLIC or EcoLip-GLIC (Figs. 2 and 3). The amide I band shapes of GLIC in all three membranes are similar, suggesting a similar global secondary structure (however, see below). There is no further shift in amide I component band intensity from 1655 cm−1 down to near 1645 cm−1 after prolonged exposure of PC-GLIC to 2H2O. There are no changes in the levels of peptide N-1H/N-2H exchange, as shown by the similar residual amide II band intensities, although both aso-GLIC and PC-GLIC are more exchanged than EcoLip-GLIC. The thermal denaturation temperature of PC-GLIC is also similar to that of both aso-GLIC and EcoLip-GLIC, and there are no changes in the cooperativity of unfolding (Table 1).

In fact, the only substantial difference observed between spectra recorded from PC-GLIC and either aso-GLIC or EcoLip-GLIC is a slight broadening of the amide I contour, noticeable near 1630 cm−1. The degree of this subtle broadening, however, varied between PC-GLIC reconstitutions. Although the structural basis of this spectral effect remains to be determined, it could reflect variations in GLIC aggregation within the membrane. Previous studies have suggested that the monodispersity of the pentameric GLIC within the membrane is lipid-sensitive (18). Monodispersity was found to be ideal in asolectin bilayers. GLIC may tend to aggregate more in PC than in other lipid environments, leading to broadening of the amide I band. Regardless, our structural data suggest that GLIC does not adopt an uncoupled conformation in PC membranes similar to that adopted by PC-nAChR.

Finally, we indirectly assessed whether PC-GLIC exhibits the ability to gate open in response to proton binding (Fig. 4). As noted, very weak or negligible Carb-induced currents are observed in oocytes injected with PC-nAChR, even though PC-nAChR fuses with the oocyte plasma membrane. In contrast, oocytes injected with PC-GLIC exhibit currents that both respond to protons in a dose-dependent manner and are sensitive to amantadine block. The maximal currents obtained upon injection of PC-GLIC are substantially higher than those in mock or uninjected oocytes and are indistinguishable from those observed in oocytes injected with either aso-GLIC or EcoLip-GLIC. The pH-activated currents are also sensitive to amantadine. The electrophysiological recordings suggest that GLIC does not adopt a conformation in PC membranes similar to the uncoupled conformation adopted by the nAChR. Even the minimal PC membrane environment appears sufficient to stabilize GLIC in a conformation that gates open in response to agonist binding.

DISCUSSION

The underlying mechanisms by which lipids modulate nAChR function have been the subject of continuous debate for over 30 years (6). There has long been a consensus that both cholesterol and anionic lipids are required in a reconstituted membrane to obtain optimal nAChR function (710, 3436). It has also been suggested that both lipids influence nAChR function by an allosteric mechanism, whereby lipids alter the functional response to acetylcholine by stabilizing differing proportions of pre-existing resting (activatable) versus desensitized or uncoupled (inactivatable) conformations (7, 29). The mechanisms by which these lipids influence function, however, are not clear. It has been suggested that some act by binding to interstitial sites between different α-helices in the transmembrane domain (13, 37). Lipids may also interact directly with the lipid-protein interface (11, 3739). Although the consensus is that lipid chemistry and thus specific lipid sites are likely important, molecular insight into any such binding sites has yet to be obtained. The lack of mechanistic insight reflects both the complexity of lipid-nAChR interactions and the inability to express site-directed mutants of the nAChR, which can be used to test proposed mechanisms of lipid-protein interactions.

Prokaryotic pLGICs provide a new opportunity for probing the molecular details of pLGIC-lipid interactions (14, 40). The prokaryotic pLGIC, GLIC, adopts a similar tertiary fold to that of the nAChR. Both GLIC and the nAChR are cation-selective ion channels, although GLIC and the nAChR are gated by protons and acetylcholine, respectively. The structural similarities of GLIC and the nAChR, as well as the added advantage that GLIC can be expressed in sufficient studies for biophysical and crystallographic studies, have led the increasing use of GLIC as a model for probing pLGIC structure (1517), basic mechanisms of pLGIC activation (1517), pLGIC-drug interactions (41, 42), etc. The ability to express large quantities of site-directed mutants finally opens the door for detailed mechanistic studies of lipid-GLIC interactions. Such studies, however, first require a detailed characterization of the effects of lipids on GLIC structure and function.

We report here a simple protocol for reconstituting the prokaryotic pLGIC, GLIC, into defined lipid membranes. Our protocol differs from the standard vesicle detergent destabilization approach typically used to form high lipid to protein ratio membranes for electrophysiological studies (18). One advantage of our approach is the high efficiency incorporation of GLIC into the model membranes (supplemental Fig. S1). It is easy to accurately adjust the lipid to protein ratio of the reconstituted membranes. In addition, this protocol can be used to form relatively low lipid to protein ratio proteoliposomes.

Our goal was to reconstitute GLIC into membranes at lipid to protein ratios of roughly 2:1 (w/w) because the resulting vesicles are ideal for structural studies, such as those used previously to characterize the uncoupled nAChR. These low lipid to protein ratio vesicles can be easily separated from both protein-free vesicles and low lipid-protein ratio protein aggregates (supplemental Fig. S1). They are ideal for spectroscopic studies because the scattering of light from the membrane vesicles (per mol of reconstituted protein) is minimized, and the spectral overlap between signals from lipid and protein is less of an issue. The higher density low lipid to protein ratio proteoliposomes are easier to pellet (particularly in higher density 2H2O buffers) and thus exchange into 2H2O. Low lipid to protein ratio vesicles are also ideal for structural studies using infrared difference spectroscopy, a technique that detects residue-specific changes in structure of the nAChR upon agonist-binding (27, 43, 44). Application of this approach to prokaryotic pLGICs would be particularly informative given the ability to express mutants and thus assign detected vibrational changes to specific amino acid side chains.

Membrane-reconstituted GLIC and the nAChR exhibit similar structural and biophysical properties. Both proteins exhibit a mixed α-helix/β-sheet secondary structure with both a substantial proportion of the polypeptide backbone exposed to aqueous solvent and a large proportion of α-helical peptides shielded from solvent and likely found in the transmembrane channel pore domain. GLIC exhibits a higher β-sheet content than the nAChR, as expected given that the predominantly β-sheet agonist-binding domain in GLIC makes up a larger proportion of the total protein structure (see below). The membrane-reconstituted GLIC also undergoes thermal denaturation, albeit at higher temperatures than the nAChR. These observations show that the reconstituted GLIC maintains the expected structural fold.

On the other hand, infrared spectroscopy detects a relatively intense vibration near 1645 cm−1 in spectra of the nAChR because of solvent-exposed α-helix and/or loop/random secondary structures. This vibration could reflect primarily the solvent-exposed α-helix and loop/random secondary structures found in the intracellular domain of the nAChR (Fig. 1). The lack of similar intensity in this region in spectra of GLIC is consistent with the lack of an intracellular domain in the GLIC crystal structure.

We used an indirect electrophysiological approach to probe the ability of the reconstituted GLIC to gate open in response to agonist binding. Injection of membrane-reconstituted GLIC into oocytes led to the appearance of proton activated currents across the oocyte plasma membrane. The oocyte membrane-incorporated GLIC responds in a dose-dependent manner to protons, and the resulting currents were blocked by the GLIC channel blocker amantadine. Both our structural and electrophysiological studies thus suggest that the reconstituted GLIC adopts a native structure that gates open in response to agonist binding.

A major goal of this work was to compare the lipid sensitivities of both GLIC and the nAChR. In particular, the nAChR in complex natural lipid membranes, such as those composed of either soybean asolectin lipids, or mixtures of defined lipids (PC plus cholesterol and anionic lipids) adopts an activatable resting conformation. In contrast, the nAChR in PC membranes lacking the two “activating lipids” adopts an uncoupled conformation that binds agonist with a resting state-like affinity but does not typically undergo agonist-induced conformational transitions. We are interested in the uncoupled nAChR because of increasing anecdotal evidence hinting that functionally uncoupled nAChRs may play a role in nicotinic receptor physiology (12). A main goal of this work was to assess whether GLIC exhibits a propensity similar to that of the nAChR to adopt an uncoupled conformation in PC bilayers.

Although our data show that GLIC activity is sensitive to lipids (see below), PC-GLIC does not exhibit the structural or functional characteristic of the uncoupled conformation adopted by PC-nAChR. Specifically, PC-GLIC does not exhibit the substantial increase in solvent accessibility of polypeptide backbone hydrogens, which has been attributed to weakened interactions between the agonist-binding and transmembrane domains. PC-GLIC does not exhibit the reduced cooperativity of thermal denaturation that is observed for PC-nAChR. Finally, unlike PC-nAChR, which remains inactive even after fusion with oocyte plasma membranes, fusion of PC-GLIC leads to an active conformation. Although further studies are required to fully characterize the functional properties of GLIC in different membranes, it appears that PC-GLIC is not locked in an uncoupled conformation that is unresponsive to agonist binding.

The finding that GLIC does not exhibit the same propensity as the nAChR to adopt an uncoupled conformation can be interpreted in light of our working model of uncoupling. This model proposes that lipids influence the coupling of binding and gating via the M4 transmembrane α-helices (one per subunit) (11), which are exposed to the surrounding lipid bilayer and thus ideally situated to sense membrane physical and/or chemical properties (Fig. 1) (45). Each M4 α-helix extends beyond the bilayer to interact directly with the Cys-loop, a key structure at the interface between the agonist-binding and transmembrane domains. By influencing the conformation of the M4 “lipid sensor,” lipids may modulate interactions between M4 and the Cys-loop (supplemental Fig. S6 and Ref. 11). Weakened M4/Cys-loop interactions could lead to a Cys-loop conformational change that ultimately reduces contact between the agonist binding and the transmembrane domains and leads to the uncoupled state.

A dynamic equilibrium may exist between coupled and uncoupled conformations where M4 is bound tightly or tilted away from the Cys-loop, respectively (46, 47). In fact, an equilibrium between M4 solvated by lipid and M4 bound tightly to the other transmembrane α-helices, M1+M3, has been demonstrated for the homologous glycine receptor (48). Significantly, aromatic-aromatic interactions play a key role driving associations between M4 and M1+M3, thus stabilizing a folded structure. In the context of the M4 lipid sensor model, aromatic-aromatic interactions could play a key role dictating the propensity of M4 to bind tightly to M1+M3 and to thus form a coupled conformation. Aromatic-aromatic interactions could play a role dictating the propensity of a pLGIC to adopt an uncoupled conformation in PC membranes.

In light of this hypothesis, we compared the aromatic-aromatic interactions that exist between M4 and M1+M3 in GLIC versus the nAChR (Fig. 6). Consistent with the above hypothesis, GLIC exhibits a plethora of aromatic-aromatic interactions between M4 and M1+M3, with clusters located in both the cytoplasmic and extracellular leaflets of the lipid bilayer. These aromatics could lead to a highly stable transmembrane domain that is resistant to the formation of an uncoupled conformation. In contrast, whereas the nAChR exhibits aromatic residues at the interface between M4 and M1+M3, there appear to be few if any direct interactions that could stabilize the nAChR in a coupled conformation where M4 binds tightly to M1+M3, although the lower resolution of the nAChR structure makes this interpretation less definitive. Although other features likely play important roles, the paucity of aromatic-aromatic interactions between M4 and M1+M3 in the nAChR may contribute to weaker M4/M1+M3 interactions and thus to the high propensity of this receptor to adopt an uncoupled conformation. The lack of aromatic-aromatic interactions may also contribute to the lower thermal stability of the nAChR relative to GLIC. Future studies should lead to definitive insight into the molecular basis of lipid sensitivity in pLGICs.

FIGURE 6.

FIGURE 6.

Aromatic-aromatic interactions may dictate the propensity of a pLGIC to adopt a lipid-dependent uncoupled conformation. Shown is a comparison of the aromatic residues located in M1, M3, and M4 of a single subunit transmembrane domain for GLIC (A) and the α-subunit of the nAChR (B). Both a side view of the transmembrane domain of each subunit and a top view looking down at the bilayer surface are shown. Note that the side view orientations of the two transmembrane domains have been rotated 180° about the long axis of each molecule relative to the side view orientation shown in the schematic diagram of uncoupling in supplemental Fig. S6, because this presents a clearer view of the aromatic-aromatic interactions at the interface between M4 and M1+M3.

Finally, it is notable that although GLIC does not exhibit the same propensity to uncouple as the nAChR, it still appears to be sensitive to its membrane environment. The dose response of membrane-reconstituted GLIC incorporated into oocyte membranes is shifted to higher proton concentrations, suggesting a weaker ability of protons to gate open the channel. A lower pH50 has also been observed in electrophysiology studies of GLIC reconstituted into asolectin membranes at high lipid-protein ratios. In fact, lipid effects may account for the altered pH50 values observed for GLIC in different heterologous expression systems (49, 50). Note that altered sensitivity to protons could reflect altered proton binding and/or altered coupling of binding to gating. Lipids may still influence the coupling of binding and gating in GLIC, albeit to a lesser extent than with the nAChR.

In addition, we detect both an increased thermal stability and a reduced level of peptide backbone N-1H/N-2H exchange after prolonged exposure to 2H2O of EcoLip-GLIC relative to both aso-GLIC and PC-GLIC. Both suggest a slightly more rigid structure in the membranes formed from E. coli polar lipid extracts. A more detailed characterization of the effects of membranes on GLIC structure should lead to further insight into the molecular coupling of pLGICs with their membrane environment.

Supplementary Material

Supplemental Data

Acknowledgments

We thank Julian Surujbali and Peter Juranka for assistance with the electrophysiological measurements.

*

This work was supported by grants from the Canadian Institute of Health Research and the Natural Sciences and Engineering Research Council of Canada (to J. E. B.), by a Bourses d'Études pour la France (to J. E. B.) from l'Ambassade de France au Canada, by grants from the South Plains Foundation and the Center for Membrane Protein Research, Texas Tech University Health Science Center (to M. P. B. and M. J.), and by a grant from the National Institutes of Health Grant NS059841 (to M. J.).

Inline graphic

This article contains supplemental Figs. S1–S6.

2
The abbreviations used are:
nAChR
nicotinic acetylcholine receptor
GLIC
Gloebacter ligand-gated ion channel
aso-GLIC
GLIC in asolectin membranes
aso-nAChR
nAChR in asolectin membranes
Carb
carbamylchoilne
DDM
dodecylmaltoside
EcoLip-GLIC
GLIC in E. coli lipid membranes
pLGIC
pentameric ligand-gated ion channel
PC
1-palmotyl-2-oleoyl-sn-glycero-3-phosphocholine
PC-GLIC
GLIC in PC membranes
PC-nAChR
nAChR in PC membranes
PA
phosphatidic acid
Chol
cholesterol.

REFERENCES

  • 1. Sine S. M., Engel A. G. (2006) Recent advances in Cys-loop receptor structure and function. Nature 440, 448–455 [DOI] [PubMed] [Google Scholar]
  • 2. Taly A., Corringer P. J., Guedin D., Lestage P., Changeux J. P. (2009) Nicotinic receptors. Allosteric transitions and therapeutic targets in the nervous system. Nat. Rev. Drug Discov. 8, 733–750 [DOI] [PubMed] [Google Scholar]
  • 3. Sine S. M. (2012) End-plate acetylcholine receptor. Structure, mechanism, pharmacology, and disease. Physiol. Rev. 92, 1189–1234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Changeux J. P. (2012) Conscious processing. Implications for general anesthesia. Curr. Opin. Anaesthesiol. 25, 397–404 [DOI] [PubMed] [Google Scholar]
  • 5. Baenziger J. E., Corringer P. J. (2011) 3D structure and allosteric modulation of the transmembrane domain of pentameric ligand-gated ion channels. Neuropharmacology 60, 116–125 [DOI] [PubMed] [Google Scholar]
  • 6. Heidmann T., Sobel A., Popot J. L., Changeux J. P. (1980) Reconstitution of a functional acetylcholine receptor. Conservation of the conformational and allosteric transitions and recovery of the permeability response; role of lipids. Eur. J. Biochem. 110, 35–55 [DOI] [PubMed] [Google Scholar]
  • 7. Baenziger J. E., Morris M. L., Darsaut T. E., Ryan S. E. (2000) Effect of membrane lipid composition on the conformational equilibria of the nicotinic acetylcholine receptor. J. Biol. Chem. 275, 777–784 [DOI] [PubMed] [Google Scholar]
  • 8. Hamouda A. K., Sanghvi M., Sauls D., Machu T. K., Blanton M. P. (2006) Assessing the lipid requirements of the Torpedo californica nicotinic acetylcholine receptor. Biochemistry 45, 4327–4337 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Fong T. M., McNamee M. G. (1986) Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry 25, 830–840 [DOI] [PubMed] [Google Scholar]
  • 10. Criado M., Eibl H., Barrantes F. J. (1982) Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry 21, 3622–3629 [DOI] [PubMed] [Google Scholar]
  • 11. daCosta C. J., Baenziger J. E. (2009) A lipid-dependent uncoupled conformation of the acetylcholine receptor. J. Biol. Chem. 284, 17819–17825 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Baenziger J. E., daCosta C. J. (2013) Molecular mechanisms of acetylcholine receptor-lipid interactions. From model membranes to human biology. Biophys. Rev. 5, 1–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Brannigan G., Hénin J., Law R., Eckenhoff R., Klein M. L. (2008) Embedded cholesterol in the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 105, 14418–14423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Bocquet N., Prado de Carvalho L., Cartaud J., Neyton J., Le Poupon C., Taly A., Grutter T., Changeux J. P., Corringer P. J. (2007) A prokaryotic proton-gated ion channel from the nicotinic acetylcholine receptor family. Nature 445, 116–119 [DOI] [PubMed] [Google Scholar]
  • 15. Hilf R. J., Dutzler R. (2008) X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature 452, 375–379 [DOI] [PubMed] [Google Scholar]
  • 16. Bocquet N., Nury H., Baaden M., Le Poupon C., Changeux J. P., Delarue M., Corringer P. J. (2009) X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature 457, 111–114 [DOI] [PubMed] [Google Scholar]
  • 17. Hilf R. J., Dutzler R. (2009) Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel. Nature 457, 115–118 [DOI] [PubMed] [Google Scholar]
  • 18. Velisetty P., Chalamalasetti S. V., Chakrapani S. (2012) Conformational transitions underlying pore opening and desensitization in membrane-embedded GLIC. J. Biol. Chem. 287, 36864–36872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Carswell C. L., Rigden M. D., Baenziger J. E. (2008) Expression, purification, and structural characterization of CfrA, a putative iron transporter from Campylobacter jejuni. J. Bacteriol. 190, 5650–5662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Sayeed W. M., Baenziger J. E. (2009) Structural characterization of the osmosensor ProP. Biochim. Biophys. Acta 1788, 1108–1115 [DOI] [PubMed] [Google Scholar]
  • 21. Hamouda A. K., Chiara D. C., Sauls D., Cohen J. B., Blanton M. P. (2006) Cholesterol interacts with transmembrane α-helices M1, M3, and M4 of the Torpedo nicotinic acetylcholine receptor. Photolabeling studies using [3H]azicholesterol. Biochemistry 45, 976–986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Reid S. E., Moffat D. J., Baenziger J. E. (1996) The selective enhancement and subsequent subtraction of atmospheric water vapour contributions from Fourier transform infrared spectra of proteins. Spectrochim. Acta A 52, 1347–1356 [Google Scholar]
  • 23. Pandhare A., Hamouda A. K., Staggs B., Aggarwal S., Duddempudi P. K., Lever J. R., Lapinsky D. J., Jansen M., Cohen J. B., Blanton M. P. (2012) Bupropion binds to two sites in the Torpedo nicotinic acetylcholine receptor transmembrane domain. A photoaffinity labeling study with the bupropion analogue [125I]-SADU-3–72. Biochemistry 51, 2425–2435 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. daCosta C. J., Baenziger J. E. (2003) A rapid method for assessing lipid:protein and detergent:protein ratios in membrane-protein crystallization. Acta Crystallogr. D Biol. Crystallogr. 59, 77–83 [DOI] [PubMed] [Google Scholar]
  • 25. Méthot N., Ritchie B. D., Blanton M. P., Baenziger J. E. (2001) Structure of the pore-forming transmembrane domain of a ligand-gated ion channel. J. Biol. Chem. 276, 23726–23732 [DOI] [PubMed] [Google Scholar]
  • 26. Baenziger J. E., Chew J. P. (1997) Desensitization of the nicotinic acetylcholine receptor mainly involves a structural change in solvent-accessible regions of the polypeptide backbone. Biochemistry 36, 3617–3624 [DOI] [PubMed] [Google Scholar]
  • 27. daCosta C. J., Michel Sturgeon R., Hamouda A. K., Blanton M. P., Baenziger J. E. (2011) Structural characterization and agonist binding to human α4β2 nicotinic receptors. Biochem. Biophys. Res. Commun. 407, 456–460 [DOI] [PubMed] [Google Scholar]
  • 28. Baenziger J. E., Méthot N. (1995) Fourier transform infrared and hydrogen/deuterium exchange reveal an exchange-resistant core of α-helical peptide hydrogens in the nicotinic acetylcholine receptor. J. Biol. Chem. 270, 29129–29137 [DOI] [PubMed] [Google Scholar]
  • 29. daCosta C. J., Medaglia S. A., Lavigne N., Wang S., Carswell C. L., Baenziger J. E. (2009) Anionic lipids allosterically modulate multiple nicotinic acetylcholine receptor conformational equilibria. J. Biol. Chem. 284, 33841–33849 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Unwin N., Fujiyoshi Y. (2012) Gating movement of acetylcholine receptor caught by plunge-freezing. J. Mol. Biol. 422, 617–634 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Alexandrov A. I., Mileni M., Chien E. Y., Hanson M. A., Stevens R. C. (2008) Microscale fluorescent thermal stability assay for membrane proteins. Structure 16, 351–359 [DOI] [PubMed] [Google Scholar]
  • 32. Morales A., Aleu J., Ivorra I., Ferragut J. A., Gonzalez-Ros J. M., Miledi R. (1995) Incorporation of reconstituted acetylcholine receptors from Torpedo into the Xenopus oocyte membrane. Proc. Natl. Acad. Sci. U.S.A. 92, 8468–8472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Méthot N., Demers C. N., Baenziger J. E. (1995) Structure of both the ligand- and lipid-dependent channel-inactive states of the nicotinic acetylcholine receptor probed by FTIR spectroscopy and hydrogen exchange. Biochemistry 34, 15142–15149 [DOI] [PubMed] [Google Scholar]
  • 34. Criado M., Eibl H., Barrantes F. J. (1984) Functional properties of the acetylcholine receptor incorporated in model lipid membranes. Differential effects of chain length and head group of phospholipids on receptor affinity states and receptor-mediated ion translocation. J. Biol. Chem. 259, 9188–9198 [PubMed] [Google Scholar]
  • 35. Rankin S. E., Addona G. H., Kloczewiak M. A., Bugge B., Miller K. W. (1997) The cholesterol dependence of activation and fast desensitization of the nicotinic acetylcholine receptor. Biophys. J. 73, 2446–2455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Ryan S. E., Demers C. N., Chew J. P., Baenziger J. E. (1996) Structural effects of neutral and anionic lipids on the nicotinic acetylcholine receptor. An infrared difference spectroscopy study. J. Biol. Chem. 271, 24590–24597 [DOI] [PubMed] [Google Scholar]
  • 37. Jones O. T., McNamee M. G. (1988) Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 27, 2364–2374 [DOI] [PubMed] [Google Scholar]
  • 38. Marsh D., Watts A., Barrantes F. J. (1981) Phospholipid chain immobilization and steroid rotational immobilization in acetylcholine receptor-rich membranes from Torpedo marmorata. Biochim. Biophys. Acta 645, 97–101 [DOI] [PubMed] [Google Scholar]
  • 39. Ellena J. F., Blazing M. A., McNamee M. G. (1983) Lipid-protein interactions in reconstituted membranes containing acetylcholine receptor. Biochemistry 22, 5523–5535 [DOI] [PubMed] [Google Scholar]
  • 40. Tasneem A., Iyer L. M., Jakobsson E., Aravind L. (2005) Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels. Genome Biol. 6, R4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Nury H., Van Renterghem C., Weng Y., Tran A., Baaden M., Dufresne V., Changeux J. P., Sonner J. M., Delarue M., Corringer P. J. (2011) X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 469, 428–431 [DOI] [PubMed] [Google Scholar]
  • 42. Weng Y., Yang L., Corringer P. J., Sonner J. M. (2010) Anesthetic sensitivity of the Gloeobacter violaceus proton-gated ion channel. Anesth. Analg. 110, 59–63 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Ryan S. E., Hill D. G., Baenziger J. E. (2002) Dissecting the chemistry of nicotinic receptor-ligand interactions with infrared difference spectroscopy. J. Biol. Chem. 277, 10420–10426 [DOI] [PubMed] [Google Scholar]
  • 44. Baenziger J. E., Ryan S. E., Goodreid M. M., Vuong N. Q., Sturgeon R. M., daCosta C. J. (2008) Lipid composition alters drug action at the nicotinic acetylcholine receptor. Mol. Pharmacol. 73, 880–890 [DOI] [PubMed] [Google Scholar]
  • 45. Unwin N. (2005) Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J. Mol. Biol. 346, 967–989 [DOI] [PubMed] [Google Scholar]
  • 46. De Almeida R. F., Loura L. M., Prieto M., Watts A., Fedorov A., Barrantes F. J. (2006) Structure and dynamics of the γM4 transmembrane domain of the acetylcholine receptor in lipid bilayers. Insights into receptor assembly and function. Mol. Membr. Biol. 23, 305–315 [DOI] [PubMed] [Google Scholar]
  • 47. Xu Y., Barrantes F. J., Luo X., Chen K., Shen J., Jiang H. (2005) Conformational dynamics of the nicotinic acetylcholine receptor channel. A 35-ns molecular dynamics simulation study. J. Am. Chem. Soc. 127, 1291–1299 [DOI] [PubMed] [Google Scholar]
  • 48. Haeger S., Kuzmin D., Detro-Dassen S., Lang N., Kilb M., Tsetlin V., Betz H., Laube B., Schmalzing G. (2010) An intramembrane aromatic network determines pentameric assembly of Cys-loop receptors. Nat. Struct. Mol. Biol. 17, 90–98 [DOI] [PubMed] [Google Scholar]
  • 49. Wang H. L., Cheng X., Sine S. M. (2011) Intra-membrane proton binding site linked to activation of a bacterial pentameric ion channel. J. Biol. Chem. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Goyal R., Salahudeen A. A., Jansen M. (2011) Engineering a prokaryotic Cys-loop receptor with a third functional domain. J. Biol. Chem. 286, 34635–34642 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Velisetty P., Chakrapani S. (2012) Desensitization mechanism in prokaryotic ligand-gated ion channel. J. Biol. Chem. 287, 18467–18477 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES